Search company, investor...

NanoBioDesign

nanobiodesign.com

Founded Year

2001

Stage

Other Investors | Alive

About NanoBioDesign

NanoBioDesign (NBD) offers a range of P450 assays to assist drug discovery

Headquarters Location

Exhibition Road Floor 12, E & EE Building

SW7 2AZ,

United Kingdom

Missing: NanoBioDesign's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NanoBioDesign's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

NanoBioDesign Frequently Asked Questions (FAQ)

  • When was NanoBioDesign founded?

    NanoBioDesign was founded in 2001.

  • What is NanoBioDesign's latest funding round?

    NanoBioDesign's latest funding round is Other Investors.

  • Who are the investors of NanoBioDesign?

    Investors of NanoBioDesign include YFM Equity Partners, NPI Ventures and Touchstone Innovations.

  • Who are NanoBioDesign's competitors?

    Competitors of NanoBioDesign include MerLion Pharmaceuticals, Visiopharm, Fluxion Biosciences, Prosarix, BioNano Genomics and 11 more.

Compare NanoBioDesign to Competitors

V
VivoPath

VivoPath is a preclinical screening company, offering the company's clients discovery and development services for in vivo testing. VivoPath aims to provide integrated in vivo studies led by established experts in drug development. Efficacy is established for animal models in the areas of metabolic disease, inflammation, neurodegenerative disease, and infectious diseases. Formulation screening is carried out to select the most appropriate delivery system for administration. Pharmacokinetic evaluation is carried out to assess exposure and bioavailability. Tolerability is assessed with evaluations of clinical signs, clinical chemistry and hematology. The resulting program aims to deliver the client an in vivo therapeutic index (TI) report on which to assess candidates for subsequent development. VivoPath can also help clients at any individual step in this preclinical screening process. VivoPath's commitment is to provide scientific expertise in in vivo drug discovery in order to increase productivity from research into drug development.

G
Gentronix Limited

Gentronix provides toxicology testing services for pharmaceuticals, agrochemicals, cosmetics, personal care and consumer products. The company enables major global brands to perform hazard and safety assessments, from early-stage discovery through to regulatory submission and approval.

M
MerLion Pharmaceuticals

MerLion Pharmaceuticals focuses on the discovery and development of drug candidates from natural sources. MerLion collaborates with leading pharmaceutical companies, biotechs and research institutes to identify and develop drug leads in a wide range of therapeutic areas.

C
Cira Discovery Sciences

Cira Discovery Sciences, Inc. was founded in 2003 and funded by BioAdvance in 2004 with the mission of discovering biomarker patterns for medical diagnostic products and drug discovery services. The company targets two key application domains, proteomics and flow cytometry, both utilized in the diagnostic and pharmaceutical fields. Cira has developed and patented methods of computational analysis of large, high-dimensionality data sets characteristic of both proteomics and flow cytometry. Advances in these fields are currently hampered by limitations in extracting valuable patentable knowledge from the data. The company ceased operations in 2008 and its intellectual property is being marketed for acquisition.

A
AC PharmaChem

AC PharmaChem, Inc. is a fast growing company providing contract research and development services of medicinal chemistry, customer based organic synthesis of special chemical reagents, intermediates, reference compounds, and synthesis of focused libraries. The company's goal is to fully support the company's pharmaceutical and biotech partners to speed up and advance their drug discovery and innovation processes. At AC PharmaChem, the company have experienced medicinal and synthetic chemists utilizing synthetic techniques and instruments to provide cost efficient and on time delivery to meet the demands of the company's customers.

Silicos Logo
Silicos

silicos aims to empower virtual screening for in silico drug discovery

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.